CEO Vivek Tiwari Steps Down To Take Board Role

Share via:


SUMMARY

Medikabazaar is reportedly undergoing a management restructuring with the company’s cofounder Vivek Tiwari stepping down as chief executive officer and taking a board role

Also, the company is undergoing an audit by accounting firm PwC, and is believed to have found discrepancies in the company’s revenue recognition process, among other issues

The company’s board was made aware of certain irregularities concerning the business and operations of the company, and with the support of its investors, it carried out an external review

Mumbai-based B2B healthcare supply chain startup Medikabazaar is reportedly undergoing a management restructuring with the company’s cofounder Vivek Tiwari stepping down as chief executive officer and taking a board role.

As per ET’s report, Medikabazaar’s board is currently finalising a new CEO.

“In addition, the board has also initiated plans to bring a new CEO into the business with experience of managing large scale businesses,” the report quoted a company spokesperson as saying.

It further added that the company is undergoing an audit by accounting firm PwC. The audit is in the final stages and is believed to have found discrepancies in the company’s revenue recognition process, among other issues.

The spokesperson further said the company has pulled in a senior professional management team to support the business. It added that the board was made aware of certain irregularities concerning the business and operations of the company, and with the support of its investors, it carried out an external review.

The startup reported a net loss of INR 20.8 Cr in FY22 as against a net profit of INR 61 Lakh in FY21. 

Though the startup reported loss in FY22, revenue from operations jumped over 3X or 175% to INR 1,552.5 Cr from INR 564.7 Cr in FY21.

Tiwari founded the company along with Ketan Malkan in 2014. Since the inception of Medikabazaar, he has been the chief executive and has been leading the company. Prior to that, he served as chief operating officer at basic chemicals manufacturer AMRA Renal Care limited for over three years.

Medikabazaar has raised a total of $191.94 Mn across six funding rounds and the last round was raised on April 12, 2022, as per Inc42’s data.





Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

CEO Vivek Tiwari Steps Down To Take Board Role


SUMMARY

Medikabazaar is reportedly undergoing a management restructuring with the company’s cofounder Vivek Tiwari stepping down as chief executive officer and taking a board role

Also, the company is undergoing an audit by accounting firm PwC, and is believed to have found discrepancies in the company’s revenue recognition process, among other issues

The company’s board was made aware of certain irregularities concerning the business and operations of the company, and with the support of its investors, it carried out an external review

Mumbai-based B2B healthcare supply chain startup Medikabazaar is reportedly undergoing a management restructuring with the company’s cofounder Vivek Tiwari stepping down as chief executive officer and taking a board role.

As per ET’s report, Medikabazaar’s board is currently finalising a new CEO.

“In addition, the board has also initiated plans to bring a new CEO into the business with experience of managing large scale businesses,” the report quoted a company spokesperson as saying.

It further added that the company is undergoing an audit by accounting firm PwC. The audit is in the final stages and is believed to have found discrepancies in the company’s revenue recognition process, among other issues.

The spokesperson further said the company has pulled in a senior professional management team to support the business. It added that the board was made aware of certain irregularities concerning the business and operations of the company, and with the support of its investors, it carried out an external review.

The startup reported a net loss of INR 20.8 Cr in FY22 as against a net profit of INR 61 Lakh in FY21. 

Though the startup reported loss in FY22, revenue from operations jumped over 3X or 175% to INR 1,552.5 Cr from INR 564.7 Cr in FY21.

Tiwari founded the company along with Ketan Malkan in 2014. Since the inception of Medikabazaar, he has been the chief executive and has been leading the company. Prior to that, he served as chief operating officer at basic chemicals manufacturer AMRA Renal Care limited for over three years.

Medikabazaar has raised a total of $191.94 Mn across six funding rounds and the last round was raised on April 12, 2022, as per Inc42’s data.





Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

‘Taxing popcorn for 0.013% revenue? Ex-CEA K Subramanian questions...

Former Chief Economic Advisor (CEA) Krishnamurthy Subramanian on Monday...

FirstCry Parent Shares Decline 5%, Stock Down 10% YTD

SUMMARY The stock recouped some losses during the intraday...

Australia’s ‘Barefoot Investor’ takes on crypto scammers stealing his...

Australian investing and finance educator Scott Pape, known...

Popular

Upcoming Events

Startup Information that matters. Get in your inbox Daily!